This post was originally published on this site
(Reuters) – The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.
The FTC said it is looking into whether Abbott Laboratories (NYSE:ABT) and other formula manufacturers have “engaged in collusion or coordination with any other market participant regarding the bidding” for state contracts, the report said, citing documents posted to FTC’s website.
